Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
About this item
Full title
Author / Creator
Grothey, Axel , Sobrero, Alberto F , Shields, Anthony F , Yoshino, Takayuki , Paul, James , Taieb, Julien , Souglakos, John , Shi, Qian , Kerr, Rachel , Labianca, Roberto , Meyerhardt, Jeffrey A , Vernerey, Dewi , Yamanaka, Takeharu , Boukovinas, Ioannis , Meyers, Jeffrey P , Renfro, Lindsay A , Niedzwiecki, Donna , Watanabe, Toshiaki , Torri, Valter , Saunders, Mark , Sargent, Daniel J , Andre, Thierry and Iveson, Timothy
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
This analysis involving patients with stage III colon cancer pooled the findings of six clinical trials regarding the effect of adjuvant-therapy duration on disease-free survival. The results varied according to drug regimen and disease subgroup.
Alternative Titles
Full title
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
Authors, Artists and Contributors
Author / Creator
Sobrero, Alberto F
Shields, Anthony F
Yoshino, Takayuki
Paul, James
Taieb, Julien
Souglakos, John
Shi, Qian
Kerr, Rachel
Labianca, Roberto
Meyerhardt, Jeffrey A
Vernerey, Dewi
Yamanaka, Takeharu
Boukovinas, Ioannis
Meyers, Jeffrey P
Renfro, Lindsay A
Niedzwiecki, Donna
Watanabe, Toshiaki
Torri, Valter
Saunders, Mark
Sargent, Daniel J
Andre, Thierry
Iveson, Timothy
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6426127
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6426127
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1713709
